Turoctocog Alfa
Turoctocog alfa is a recombinant human coagulation factor VIII (B-domain truncated) used for the prevention and treatment of bleeding episodes in patients with hemophilia A, a hereditary bleeding disorder caused by factor VIII deficiency. It replaces the missing clotting factor, restoring the intrinsic coagulation pathway and enabling normal hemostasis. It is produced by recombinant DNA technology in Chinese hamster ovary cells.
Mechanism of Action
As a recombinant protein, it replicates the function of the naturally occurring human protein, supplementing or replacing deficient endogenous production to restore normal physiological activity.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
As a recombinant protein, it replicates the function of the naturally occurring human protein, supplementing or replacing deficient endogenous production to restore normal physiological activity.
HBD / HBA
- / -
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Frequently Asked Questions
Turoctocog alfa is a recombinant human coagulation factor VIII (B-domain truncated) used for the prevention and treatment of bleeding episodes in patients with hemophilia A, a hereditary bleeding disorder caused by factor VIII deficiency. It replaces the missing clotting factor, restoring the intrinsic coagulation pathway and enabling normal hemostasis. It is produced by recombinant DNA technology in Chinese hamster ovary cells.
As a recombinant protein, it replicates the function of the naturally occurring human protein, supplementing or replacing deficient endogenous production to restore normal physiological activity.
Yes, Turoctocog Alfa is an approved drug. It has reached clinical phase 4. It is classified as a Protein.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2108286. Open-access bioactivity database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="turoctocog-alfa"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/turoctocog-alfa/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/turoctocog-alfa/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/turoctocog-alfa/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="turoctocog-alfa"></drugfyi-drug>